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report, cytologic features typical of melanocytoma were obtained by fine needle aspiration biopsy (FNAB). FNAB can be used
in difficult diagnostic cases if a good sample is obtained, this technique has an accuracy of more than 99% in tumors larger than
3 mm; however, false-negative and false-positive results may be obtained. Its risk of local spread is very small, an advantage over
incisional biopsy. The most common complication is intralesional hemorrhage and hyphema.
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Zimmerman and Garron suggested the term ‘‘melanocy-
toma’’ to describe deeply pigmented tumor of the optic
nerve head1 is an uncommon tumor of the uveal tract, which
is generally regarded as benign, having the ability for inva-
sion of local tissues.2 Classically it is described at the optic
nerve head, but it is encountered less frequently at the ciliary
body, and there are rare reports of occurrence in the iris,
sclera, conjunctiva, and choroid. In some cases, iris or ciliary
body melanocytoma can show progressive growth or even
extrascleral involvement; this aspect makes clinical differenti-
ation from malignant melanoma difficult.3 Moreover, iris mel-
anocytoma has a peculiar tendency to undergo necrosis with
shedding of pigment on the iris and trabecular meshwork,4
this can produce secondary glaucoma and heterochromia.
Despite its benign nature, iris melanocytoma growth occurs
in 23% of cases at 5 years and 48% of cases at 10 years.5
Malignant transformation is rare.Case report
A 9 year-old girl was referred to the King Khaled Eye Spe-
cialist Hospital with the diagnosis of iris tumor in her left eye.
For the past two months, she had experienced intermittent
itching and redness in her left eye. On ophthalmic examina-
tion, the best uncorrected visual acuity was 20/20 in each
eye. The intraocular pressures (IOP) were 13 mm Hg in the
right eye and 20 mmHg in the left. The biomicroscopic exam-
ination of the right eye was within normal limits. The left eye
had a dark brown lobulated lesion about 3  4 mm located in
the lower nasal quadrant of the iris between 7 and 8 o’clock.
It appeared to be solid, approached but did not involve the
pupil. The peripheral part of the lesion is separated from
the angle with the normal iris. Inferiorly there was another
crescent like pigmented lesion at 6 o’clock. The surface of
the iris has numerous small-pigmented lesions more concen-
trated around the lesion and disappears away from it. The
mass seemed to be adhered to the peripheral posteriore:
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Figure 1b. Extension of the iris lesion obstructing the gonioscopic view
of the chamber angle between 7 and 8 o’clock. The remainder of the
angle was open with a moderate amount of pigmentation covering the
scleral spur and trabecular meshwork.
278 S. Awaji et al.cornea (Fig. 1a). Extension of the lesion obstructed the
gonioscopic view into the chamber angle between 7 and 8
o’clock. The remainder of the angle was open with a moder-
ate amount of pigmentation covering the scleral spur and tra-
becular meshwork (Fig. 1b). There were moderate anterior
chamber reaction 3 + cells, and 1 + flare with few pigment
deposits on the posterior surface of the cornea. Ultrasound
Biomicroscopy (UBM) showed a large homogeneous solid
mass and a thickness of about 2.53 mm, the ciliary body
was free from lesion, UBM was suggestive of iris melanoma
(Fig. 1c). Uveitis work-up and systemic evaluation were unre-
markable. Based on overall appearance and location malig-
nancy could not be ruled out. Differential diagnosis
included melanoma, nevus, melanocytoma and others. Fine-
Needle Aspiration Biopsy (FNAB) as well as anterior chamber
aqueous aspiration were performed and cytological smears
of specimen showed highly pigmented plump polyhedral
cells with abundant pigmented cytoplasm and round regular
normal size nuclei and no evidence of pleomorphism, the
cells showed low nuclear–cytoplasmic ratio (N/C ratio)
(Fig. 2), the appearance was suggestive of iris melanocytoma.Figure 1c. UBM showed a large homogeneous solid mass with a
thickness of about 2.53 mm. The ciliary body was free from lesion.Surgical technique for FNAB
The FNAB technique of the iris involves proper instrumen-
tation, planning of tumor approach, handling of harvested
cells, and preparation and interpretation of cytologic speci-
mens. In our case clear corneal incision was made superiona-
sally as paracentesis using 75 blade. Aqueous was aspirated
with a 27 gauge cannula and viscoelastic substance was in-
jected into the anterior chamber to form it and prevent any
possible cells seed or bleeding that might occur. FNAB was
done using a 25-gauge needle attached to a 3-ml syringe.
Inferior clear corneal approach was selected for aspiration.
Aspiration point was at the thickest portion of the tumor
where the tumor was adhered to the cornea. A gentle sliding
motion of the needle within the mass was performed to shave
and loosen cells for aspiration. Aspiration of the 3-ml syringe
was performed over 5 s to confirm that the needle was com-
pletely within the mass and not simply aspirating aqueous.
Aspiration was maintained for a few seconds with the needle
in the tumor and also as the needle was withdrawn from the
eye. The needle was then removed slowly from the eye and
bleeding occurred during the aspiration into the anterior
chamber. The anterior chamber was refilled using balanced
salt solution (BSS) after removing viscoelastic substance andFigure 1a. Picture of the left eye had a dark brown lobulated lesion
about 3 4 mm located in the lower nasal quadrant of the iris between 7
and 8 o’clock. Inferiorly there was another crescent like lesion at 6 o’clock.
Figure 2. Direct smear of FNAB showing melanocytoma cells  400 H&E.stromal hydration was performed to the paracentesis site.
There was very little aspiration material. The aspirated cells,
located predominantly in the needle tip and wall of syringe,
were flushed into the syringe using BSS. Immediately after
collection, the sample was transported to the Cytology labo-
ratory and was processed within 24 h of collection.Clinical course
Recovery was satisfactory. On the first postoperative day,
uncorrected visual acuity of the left eye was 20/100 with
hyphema and blood clot in the anterior chamber with +3
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tion over the endothelium and along with needle track
(Fig. 3a). Intraocular pressure was elevated immediately post-
operative, but lowered to 16 mmHg with Timolol 0.5% twice
daily. Prior to discharge IOP was 20 mmHg OS without treat-
ment with resolving hyphema. Later on sector iridectomy was
done to excise the lobulated lesion between 7 and 8 o’clock
to avoid the risk of melanocytomalytic glaucoma. The other
pigmented lesion at 6 o’clock was collected material of pig-
ments and also all the diffuse pigments on the iris surface that
were more abundant closer to the lesion and they aspirated
easily with Simcoe needle (Fig. 3b). There was no residual iris
tumor and no recurrence after 23 months of tumor removal
with normal IOP without treatment. The best uncorrected vi-
sual acuity was 20/20 with quiet anterior chamber, and
remaining pigments on the endothelium and along the cor-
neal aspiration tract. The histopathologic appearance of the
iris tissue was typical of melanocytoma arising within the iris
stroma. The cells were polyhedral in shape with large melanin
granules and regular uniform nuclei (Fig. 4), the diagnosis of
iris melanocytoma was confirmed.Discussion
Iris melanocytoma is a rare variant of iris nevus with typical
clinical and histopathologic features that may be of value in
differentiating it from other nevi and melanomas. It presents
as a darkly pigmented nodular mass with a mossy granular
surface and no intrinsic vessels.6 The differential diagnosisFigure 3a. Post FNAB picture with hyphema, and blood clot around the
lesion with pigmentation over the endothelium as well as the needle
track.
Figure 3b. Slit-lamp appearance of the left eye after sector iridectomy
showing complete excision of the iris lesions with some pigments along
the aspiration tract.of a pigmented tumor of the ciliary body and iris includes
adenoma, adenocarcinoma, medulloepithelioma and iris epi-
thelium pigment cyst, epithelial inclusion cyst, and most
importantly, malignant melanoma. Although melanocytoma
can usually be distinguished histopathologically, it can be dif-
ficult to differentiate clinically, especially from a malignant
melanoma. Our patient has characteristic differentiating fea-
tures such as color and diffuse pigmentation, although the
pigmented condensation at 6 o’clock was thought to be a
separate lesion. Fine needle aspiration biopsy is helpful in
establishing the diagnosis and provides an efficient, econom-
ical, and relatively safe method without potential risk with
better planning for excision, this was evident in our case
which is similar to the one reported by El-Harazi et al.7 In a
clinical study by Shields and associates of 200 patients re-
ferred for suspected iris melanoma, 158 patients (76%) were
found to have lesions other than melanoma and these were
termed as pseudomelanomas. The most common pseudo-
melanomas included iris cyst (38%) and iris nevus (31%). In
that series, only one pseudomelanoma (0.5%) was an iris mel-
anocytoma.8 Iris melanocytoma can undergo spontaneous
necrosis with resultant pigment dispersion or shedding of
melanocytoma cells and/or melanophages into the anterior
chamber, causing secondary glaucoma or heterochromia.9
Macrophages that ingest pigment particles released from
the necrotic tumor may cause secondary open-angle glau-
coma by mechanically obstructing the trabecular meshwork.
The term ‘melanocytomalytic glaucoma’ has been used in
the literature to describe such a phenomenon.10 The anterior
uveitis that is often present can also cause permanent dam-
age of the aqueous outflow. Well-defined nodular melanocy-
tomas can be successfully resected, eliminating the source of
the pigment. Fine-needle aspiration biopsy can be done as
an outpatient procedure and is safe and effective, it can be
used in difficult diagnostic cases; this technique has an accu-
racy of more than 99%. Its risk of local spread is very small, an
advantage over incisional biopsy. The most common compli-
cation is intralesional hemorrhage,6 that may have an effect
and cause hyphema as it occurred in our case. The manage-
ment of suspected iris melanocytoma is usually cautious
observation. When noninvasive diagnostic techniques fail to
establish the diagnosis or tumor growth is documented,
fine-needle aspiration biopsy or local resection using iridec-
tomy, iridogoniectomy, or iridogoniocyclectomy is per-
formed.11 Local resection can also be used to treat
secondary glaucoma caused by necrotic melanocytoma.12 In
conclusion this case proves that iris melanocytoma can occur
in young age group without significant symptoms and mayFigure 4. Histopathologic appearance of the non-cohesive melanocy-
toma cells of the lesion  400 H&E.
280 S. Awaji et al.cause condensed pigmented areas that may look like a tu-
mor. High IOP may occur transiently following resection. Lo-
cal resection can also be used to decrease the risk of
secondary glaucoma caused by necrotic melanocytoma.
FNAB is a good tool in the diagnosis of iris melanocytoma
and anterior chamber tap might not be helpful. Recurrence
of the tumor following resection has not been observed with
good outcome.Conflicts of interest
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